Shares of Smith & Nephew SNATS, Inc. (NYSE:SNN – Get Free Report) have been assigned an average rating of “Hold” from the eight ratings firms that are presently covering the firm, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a hold rating and one has given a strong buy rating to the company. The average 12 month price objective among brokers that have covered the stock in the last year is $35.75.
A number of equities analysts have recently weighed in on SNN shares. Kepler Capital Markets upgraded Smith & Nephew SNATS to a “strong-buy” rating in a report on Monday, November 17th. Sanford C. Bernstein set a $37.50 target price on shares of Smith & Nephew SNATS and gave the stock a “market perform” rating in a research note on Tuesday, October 14th. Canaccord Genuity Group dropped their price target on shares of Smith & Nephew SNATS from $36.00 to $34.00 and set a “hold” rating for the company in a research report on Tuesday, November 11th. Royal Bank Of Canada downgraded shares of Smith & Nephew SNATS from an “outperform” rating to a “sector perform” rating in a research note on Monday, December 15th. Finally, Wall Street Zen raised shares of Smith & Nephew SNATS from a “buy” rating to a “strong-buy” rating in a research report on Saturday, January 10th.
Read Our Latest Report on Smith & Nephew SNATS
Smith & Nephew SNATS Price Performance
Institutional Investors Weigh In On Smith & Nephew SNATS
A number of institutional investors have recently modified their holdings of the company. Caitong International Asset Management Co. Ltd acquired a new position in Smith & Nephew SNATS during the 3rd quarter worth about $41,000. AlphaCore Capital LLC acquired a new position in Smith & Nephew SNATS in the 2nd quarter valued at about $44,000. Northwestern Mutual Wealth Management Co. increased its stake in Smith & Nephew SNATS by 105.8% during the third quarter. Northwestern Mutual Wealth Management Co. now owns 1,385 shares of the medical equipment provider’s stock worth $50,000 after purchasing an additional 712 shares during the period. Huntington National Bank increased its stake in Smith & Nephew SNATS by 1,837.0% during the third quarter. Huntington National Bank now owns 1,414 shares of the medical equipment provider’s stock worth $51,000 after purchasing an additional 1,341 shares during the period. Finally, Smartleaf Asset Management LLC lifted its position in shares of Smith & Nephew SNATS by 1,222.3% during the third quarter. Smartleaf Asset Management LLC now owns 2,486 shares of the medical equipment provider’s stock worth $88,000 after purchasing an additional 2,298 shares in the last quarter. 25.64% of the stock is owned by institutional investors and hedge funds.
About Smith & Nephew SNATS
Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.
In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.
See Also
- Five stocks we like better than Smith & Nephew SNATS
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Wall Street Alert: Buy AES
- Trump’s Hand-Written Letter Will Shock his Haters
- Bitcoin is down but your income is about to explode
- A month before the crash
Receive News & Ratings for Smith & Nephew SNATS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew SNATS and related companies with MarketBeat.com's FREE daily email newsletter.
